KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Operating Expenses (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Operating Expenses for 11 consecutive years, with $555.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses rose 35.01% year-over-year to $555.2 million, compared with a TTM value of $2.0 billion through Dec 2025, up 20.04%, and an annual FY2025 reading of $2.0 billion, up 20.04% over the prior year.
  • Operating Expenses was $555.2 million for Q4 2025 at Medpace Holdings, up from $518.1 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $555.2 million in Q4 2025 and bottomed at $212.4 million in Q1 2021.
  • Average Operating Expenses over 5 years is $366.6 million, with a median of $394.7 million recorded in 2023.
  • The sharpest move saw Operating Expenses increased 0.03% in 2024, then surged 35.01% in 2025.
  • Year by year, Operating Expenses stood at $253.7 million in 2021, then rose by 25.22% to $317.7 million in 2022, then rose by 29.41% to $411.1 million in 2023, then increased by 0.03% to $411.2 million in 2024, then skyrocketed by 35.01% to $555.2 million in 2025.
  • Business Quant data shows Operating Expenses for MEDP at $555.2 million in Q4 2025, $518.1 million in Q3 2025, and $477.0 million in Q2 2025.